Wordt geladen...
Patient-Specific Dosimetry Using Pretherapy [(124)I]m-iodobenzylguanidine ([(124)I]mIBG) Dynamic PET/CT Imaging Before [(131)I]mIBG Targeted Radionuclide Therapy for Neuroblastoma
PURPOSE: Iodine-131-m-iodobenzylguanidine ([(131)I]mIBG) targeted radionuclide therapy (TRT) is a standard treatment for recurrent or refractory neuroblastoma with response rates of 30–40%. The aim of this study is to demonstrate patient-specific dosimetry using quantitative [(124)I]mIBG PET/CT imag...
Bewaard in:
| Gepubliceerd in: | Mol Imaging Biol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4336853/ https://ncbi.nlm.nih.gov/pubmed/25145966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-014-0783-7 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|